Roger Piqué Pijuan

Director at Althia Health SL

Roger Piqué Pijuan

Roger Piqué Pijuan

Director at Althia Health SL

Overview
RelSci Relationships

1204

Number of Boards

10

Contact Data
Trying to get in touch with Roger Piqué Pijuan? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Roger Piqué Pijuan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Partner at Inveready Asset Management SGEIC SA

Relationship likelihood: Strong

Managing Partner at Inveready Asset Management SGEIC SA

Relationship likelihood: Strong

Executive President at Althia Health SL

Relationship likelihood: Strong

Executive Director & Chief Executive Officer at Althia Health SL

Relationship likelihood: Strong

Former Director at Althia Health SL

Relationship likelihood: Strong

Former Director at Althia Health SL

Relationship likelihood: Strong

Group Chief Executive Officer at Codeoscopic SA

Relationship likelihood: Strong

Investment Director at Inveready Asset Management SGEIC SA

Relationship likelihood: Strong

Director at Althia Health SL

Relationship likelihood: Strong

Co-Founder at Ability Pharmaceuticals SL

Relationship likelihood: Strong

Paths to Roger Piqué Pijuan
Potential Connections via
Relationship Science
You
Roger Piqué Pijuan
Director at Althia Health SL
Education

On 18 June 1990, Catalan Parliament gave the go-ahead for the creation of a new public university in Catalonia, Pompeu Fabra University, inspired by the principles of freedom, democracy, justice, equality, independence and plurality. From its beginnings, this young academic institution set itself two main objectives: to train responsible professionals and citizens fully committed to civic values, and to contribute towards the development of an outstanding research.

University of Barcelona is the most formidable public institution of higher education in Catalonia, catering to the needs of the greatest number of students and delivering the broadest and most comprehensive offering in higher educational courses. The UB is also the principal centre of university research in Spain and has become a European benchmark for research activity, both in terms of the number of research programmes it conducts and the excellence these have achieved.

Career History
General Partner
2008 - Current

INVEREADY is an active manager which invests in innovative companies in the biotech, medical equipment, nanotechnology, renewable energy, advanced software and ICT sectors. Their geographic focus is on Spain.The firm seeks to participate in first rounds of financing, making maximum direct investments of EUR 100,000-500,000, which is usually supplemented by public funds for innovative technology companies and other private resources. The typically take minority and significant minority stakes in their investee companies and expect to hold investments for five to eight years.INVEREADY provides advice on preparing financial plans and optimizing business plans, finding investors for seed-stage financing, structuring capital searches, advice in contract negotiations, negotiation and management of various public financing instruments for innovative companies such as CDTI NEOTEC, ENISA, ICF, EUROCAN, PROFIT, Ayudas Autonómicas, participation in the CENIT program or other European programs.

Director
Current

Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. It offers medical treatment for oncology, radiology, cardiology, ophthalmology, and dermatology. The firm operates through the following segments: Telediagnosis, Diagnosis, Radiotherapy, Research & Development, and Smart and Big Data. The company was founded by Carlos Cordón-Cardó on January 4, 2007 and is headquartered in Barcelona, Spain.

GP
Current

Inveready Capital Co. SL is a company headquartered in Barcelona, Spain, involved in venture capital/private equity. It was founded by Josep María Echarri Torres.

Boards & Committees
Director
2011 - Current

Codeoscopic SA provides information technology services. The company was founded on April 3, 2009 and is headquartered in Madrid, Spain.

Director
Current

Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain.

Director
Current

X-Ray Imatek SL designs, manufactures and sells x-ray detectors. Its products portfolio includes eX Series and XRI UNO. Its services include Detector Packaging and Lab Services. The company was founded by Carlos Sánchez Sánchez, Enrique Fernandez, and Mokhtar Chmeissani Raad on June 12, 2006 and is headquartered in Barcelona, Spain.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Roger Piqué Pijuan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Roger Piqué Pijuan's profile does not indicate a business or promotional relationship of any kind between RelSci and Roger Piqué Pijuan.